参考文献/References:
[1]Gopinath R,Ayya SS.Neurogenic stress cardiomyopathy:What do we need to know [J].Ann Card Anaesth,2018,21(3):228-234.[2]Chen Z,Venkat P,Seyfried D,et al.Brain-Heart Interaction:Cardiac Complications After Stroke [J].Circ Res,2017,121(4):451-468.[3]Mazzeo AT,Micalizzi A,Mascia L,et al.Brain-heart crosstalk:the many faces of stress-related cardiomyopathy syndromes in anaesthesia and intensive care [J].Br J Anaesth,2014,112(5):803-815.[4]Ganesh A,Qadri YJ,Boortz-Marx RL,et al.Stellate Ganglion Blockade:an Intervention for the Management of Ventricular Arrhythmias [J].Curr Hypertens Rep,2020,22(12):100.[5]Wen S,Chen L,Wang TH,et al.The efficacy of ultrasound-guided stellate ganglion block in alleviating postoperative pain and ventricular arrhythmias and its application prospects [J].Neurol Sci,2021,42(8):3121-3133.[6]Samagh N,Panda NB,Gupta V,et al.Impact of Stellate Ganglion Block in the Management of Cerebral Vasospasm:A Prospective Interventional Study [J].Neurol India,2022,70(1):289-295.[7]Powers WJ,Rabinstein AA,Ackerson T,et al.Guidelines for the Early Management of Patients With Acute Ischemic Stroke:2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke:A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [J].Stroke,2019,50(12):e344-e418.[8]Kilbourn KJ,Ching G,Silverman DI,et al.Clinical outcomes after neurogenic stress induced cardiomyopathy in aneurysmal sub-arachnoid hemorrhage:a prospective cohort study [J].Clin Neurol Neurosurg,2015,128:4-9.[9]Akashi YJ,Nef HM,M?觟llmann H,et al.Stress cardiomyopathy [J].Annu Rev Med,2010,61:271-286.[10]Lee VH,Oh JK,Mulvagh SL,et al.Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage [J].Neurocrit Care,2006,5(3):243-249.[11]Moussouttas M,Mearns E,Walters A,et al.Plasma Catecholamine Profile of Subarachnoid Hemorrhage Patients with Neurogenic Cardiomyopathy [J].Cerebrovasc Dis Extra,2015,5(2):57-67.[12]Ziaka M,Exadaktylos A.The Heart Is at Risk:Understanding Stroke-Heart-Brain Interactions with Focus on Neurogenic Stress Cardiomyopathy-A Review [J].J Stroke,2023,25(1):39-54.[13]Narouze S.Ultrasound-guided stellate ganglion block:safety and efficacy [J].Curr Pain Headache Rep,2014,18(6):424.[14]Deng JJ,Zhang CL,Liu DW,et al.Treatment of stellate ganglion block in diseases:Its role and application prospect[J].World J Clin Cases,2023,11(10):2160-2167.[15]Gunduz OH,Kenis-Coskun O.Ganglion blocks as a treatment of pain: current perspectives [J].J Pain Res,2017,10:2815-2826.[16]Mayo EC,Lloren NV.Effectiveness of stellate ganglion blockade on refractory ventricular arrhythmias:a systematic review protocol [J].JBI Database System Rev Implement Rep,2018,16(5):1161-1166.[17]Wittwer ED,Radosevich MA,Ritter M,et al.Stellate Ganglion Blockade for Refractory Ventricular Arrhythmias:Implications of Ultrasound-Guided Technique and Review of the Evidence [J].J Cardiothorac Vasc Anesth,2020,34(8):2245-2252.[18]Janse MJ,Schwartz PJ,Wilms-Schopman F,et al.Effects of unilateral stellate ganglion stimulation and ablation on electrophysiologic changes induced by acute myocardial ischemia in dogs[J].Circulation,1985,72(3):585-595.[19]Przybylski A,Romanek J,Chlebus M,et al.Percutaneous stellate ganglion block as an adjunctive therapy in the treatment of incessant ventricular tachycardia [J].Kardiol Pol,2018,76(6):1018-1020.[20]Du Y,Demillard LJ,Ren J.Catecholamine-induced cardiotoxicity:A critical element in the pathophysiology of stroke-induced heart injury[J].Life Sci,2021,287:120106.[21]Cui C,Zhou XK,Zhu Y,et al.[Repeated stellate ganglion blockade for the treatment of ventricular tachycardia storm in patients with nonischemic cardiomyopathy:a new therapeutic option for patients with malignant arrhythmias][J].Chin J Cardiol,2023,51(5):521-525.